Stewart Campbell

Stewart Campbell

Company: Axial Therapeutics

Job title: CEO


Understand How an Interventional Strategy of Metabolite Removal is Being Translated into a Clinical Setting 3:30 pm

Microbial metabolites have been implicated in many neurological conditions, from neurodevelopmental and behavioral disorders to neurodegenerative diseases Axial, in collaboration with its scientific founder, has established that metabolites derived from the gut microbiome can reach the brain and alter oligodendrocyte maturation, and hence myelination capacity, which can be tied to behavioral changes (Nature, accepted) A…Read more

day: Day Two – Track B – 2

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.